Rural Health
News by Topic: Legislation and regulations
CMS: Medicare and Medicaid Programs; Application From The Joint Commission for Continued Approval of its Hospice Accreditation Program
Federal Register
Jun 2, 2025 - The Centers for Medicare & Medicaid Services (CMS) announced the approval of The Joint Commission for continued recognition as a national accrediting organization for hospices that wish to participate in Medicare or Medicaid programs. This approval is effective June 18, 2025 – June 18, 2030.
Source: Federal Register
CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request
Federal Register
May 30, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) End Stage Renal Disease Annual Facility Survey Form and 2) Service Level Data Collection for Initial Determinations and Appeals. Comments are due by June 30, 2025.
Source: Federal Register
May 29, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical corrections to the April 15, 2025, final rule. These corrections are effective May 29, 2025.
Source: Federal Register
FDA: Revocation of Four Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability
Federal Register
May 29, 2025 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Pfizer Inc., MAWD Laboratories, and Nuclein, LLC (merged with Molecular Diagnostics Inc.) related to COVID-19 detection and diagnosis tests.
Source: Federal Register
CMS: Medicare Program; FY 2026 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements
Federal Register
May 21, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making a correction to the April 30, 2025, proposed rule.
Source: Federal Register
May 21, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making a correction to the April 30, 2025, proposed rule.
Source: Federal Register
FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Federal Register
May 21, 2025 - The Food and Drug Administration has revoked Emergency Use Authorizations issued to Fresenius Medical Care North America (Fresenius) multiFiltrate PRO System and multiBic/multiPlus solutions (EUA 048) and to Baxter Healthcare Corp. (Baxter) for REGIOCIT (EUA 068). These revocations are effective January 16, 2025.
Source: Federal Register
May 16, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical and typographic corrections to the December 9, 2024, final rule and the December 30, 2024, correcting amendment. The corrections and correcting amendment are effective May 16, 2025, and applicable beginning January 1, 2025.
Source: Federal Register
HHS: Notification of HHS Documents Identified for Rescission
Federal Register
May 14, 2025 - Notice from the U.S. Department of Health and Human Services (HHS) rescinding four informal guidance documents: 1) Extension of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures; Extension of Effective Date With Modification; 2) Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Repeal of Current Regulations and Issuance of New Regulations: Delay of Effective Date and Resultant Amendments to the Final Rule; 3) Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder; and 4) Notification of Interpretation and Enforcement of Section 1557 of the Affordable Care Act and Title IX of the Education Amendments of 1972.
Source: Federal Register
HHS: Request for Information (RFI): Ensuring Lawful Regulation and Unleashing Innovation To Make American Healthy Again
Federal Register
May 14, 2025 - Notice from the U.S. Department of Health and Human Services (HHS) seeking comments on how to dramatically deregulate across all areas the Department touches. Specifically, HHS welcomes submissions explaining how regulations, guidance, paperwork requirements, and other regulatory obligations can be repealed. Comments are due within 60 days of the publication of this notice, which is scheduled for May 14, 2025.
Source: Federal Register